During the past decade, Unidad de Investigación en Salud conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Unidad de Investigación en Salud" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Allergan" with 3 trials sponsored and "Actelion" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Unidad de Investigación en Salud" #1 collaborator was "Bayer" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Unidad de Investigación en Salud" are "Diabetes Mellitus" (3 trials), "Gastroparesis" (3 trials), "Cardiovascular Disease" (2 trials), "Migraine" (2 trials) and "Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Unidad de Investigación en Salud" in a lesser frequency.

Most popular intervention types in "Unidad de Investigación en Salud" are "Drug" (19 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ocrelizumab" (3 trials), "Relamorelin" (3 trials), "Abemaciclib" (2 trials) and "Galcanezumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Unidad de Investigación en Salud" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Unidad de Investigación en Salud". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Unidad de Investigación en Salud, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Unidad de Investigación en Salud, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".